Effects of high and low molecular soluble factors of the bone marrow on antibody formation and pain sensitivity in animals
Ianovskiĭ, O.G.; Zakharova, L.A.; Vasilenko, A.M.
Biulleten' Eksperimental'noi Biologii i Meditsiny 109(1): 55-57
1990
ISSN/ISBN: 0365-9615 PMID: 2334799 Document Number: 354813
In addition to the immunostimulating activity, bone marrow mediators, myelopeptides (MP) show the dose-dependent effect on the development of pain sensitivity in mice. When injected in nanogram amounts, MP induce hyperalgesia and 3-9 fold higher production of antibodies against SREC. When injected in milligram amounts, they exhibit hypoalgesic effect and no influence on antibody production. Immunostimulating effect in MP (mol, mass less than 1 KD, fraction 3) is accompanied with hypoalgesia. Bone marrow factors of mol. masses 40-150 KD (fraction 1) eluted at Sephadex G-25 gel-filtration before MP enhance the pain sensitivity tHreshold and show a potent immunodepressive effect. Thus the bone marrow factors are capable of exhibiting the opposite effects on the immune system in the pain control system that evidences the tight interrelation between these systems.